Propionic Acid

Propionic Acid

SCHEMBL4157737

CCC(=O)O.O=c1[nH]c2ccc(-c3cccnc3)cc2c2cc[nH]c12

nearest known ligand 0.46

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NR4A2 P43354 1/20 0.46
MMP2 P08253 1/20 0.44
MMP13 P45452 1/20 0.44
MMP14 P50281 1/20 0.44
DYRK1A Q13627 5/20 0.43
ABL1 P00519 1/20 0.43
PTGES O14684 1/20 0.43
CYP3A4 P08684 1/20 0.43
CYP2C9 P11712 1/20 0.43
CYP2C19 P33261 1/20 0.43
TLR8 Q9NR97 2/20 0.42
TLR7 Q9NYK1 2/20 0.42
DHODH Q02127 1/20 0.41
CDK7 P50613 1/20 0.41
METAP2 P50579 1/20 0.41
CYP1A2 P05177 1/20 0.41
GSK3B P49841 1/20 0.41
KMO O15229 1/20 0.41
WNT1 P04628 1/20 0.41
PRMT5 O14744 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Propionic Acid SCHEMBL4153840 0.89 PIM1 (0.44) NR4A2MMP2MMP13PTGESGSK3B
Propionic Acid SCHEMBL4166173 0.84 GRIN2D (0.41) CYP3A4CYP2C9DHODHGSK3B
Propionic Acid SCHEMBL4164407 0.83 TLR8 (0.39) PTGESTLR8TLR7METAP2
Propionic Acid SCHEMBL4157572 0.83 GRIN2D (0.40) NR4A2PTGESGSK3B
Propionic Acid SCHEMBL4162600 0.82 PARP1 (0.38) NR4A2MMP2MMP13CYP2C19GSK3B
Propionic Acid SCHEMBL4163092 0.82 GRIN2D (0.47) TLR8TLR7DHODH
Propionic Acid SCHEMBL4162124 0.82 RIOK2 (0.50)
Propionic Acid SCHEMBL4160151 0.81 PTGS2 (0.48) ABL1METAP2GSK3B
Propionic Acid SCHEMBL4153800 0.81 TRIM24 (0.43) NR4A2PTGESGSK3BFASN
Propionic Acid SCHEMBL4167721 0.81 PRKAG1 (0.46) MMP2MMP13DYRK1AGSK3B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8426437-B2 Pyrroloquinoline derivatives and their use as protein kinases inhibitors PIERRE FABRE MEDICAMENT (FR) 2013-04-23 US claimed
US-20090042876-A1 Pyrroloquinoline Derivatives And Their Use As Protein Kinases Inhibitors PIERRE FABRE MEDICAMENT (FR) 2009-02-12 US claimed
US-8426437-B2 Pyrroloquinoline derivatives and their use as protein kinases inhibitors PIERRE FABRE MEDICAMENT (FR) 2013-04-23 US disclosed
US-20090042876-A1 Pyrroloquinoline Derivatives And Their Use As Protein Kinases Inhibitors PIERRE FABRE MEDICAMENT (FR) 2009-02-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090042876-A1 Pyrroloquinoline Derivatives And Their Use As Protein Kinases Inhibitors MAP3K1, MAP3K2, MAP3K7 NR4A2 3122/4885MMP2 1886/4885MMP13 3517/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.